# Amrit Baral: Cannabis and Psychedelic Use Among Older U.S. Cancer Survivors > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychedelic-use-older-cancer-survivors-estimates/ > **Published:** 2026-04-25T17:03:58-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:10:39-04:00 > **Clinical Summary:** Explore psychedelic use older cancer survivors with clinical estimates to inform screening and safety in symptom management for this vulnerable group. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Cancer CareGeriatricsPsychedelicsCannabisSymptom Management Why This Matters Understanding psychoactive substance use patterns among older cancer survivors is clinically essential as this population faces complex symptom management needs, potential drug interactions, and age-related pharmacokinetic changes. These data inform clinical screening protocols and safety considerations for an increasingly prevalent patient population. Clinical Summary This analysis examines cannabis and classic psychedelic use patterns among older U.S. cancer survivors, a demographic with unique clinical considerations including polypharmacy, altered drug metabolism, and complex symptom profiles. The study provides population-level estimates that help contextualize clinical encounters where substance use may be relevant to cancer-related symptom management. Understanding prevalence patterns informs clinical decision-making around screening, safety monitoring, and therapeutic discussions in this vulnerable population. Dr. Caplan’s Take “These prevalence data remind us that older cancer survivors are using these substances whether we ask about it or not. The clinical imperative is proactive screening and honest dialogue about use patterns to optimize safety and therapeutic outcomes.” Clinical Perspective 🧠 Clinicians caring for older cancer survivors should systematically screen for cannabis and psychedelic use, particularly given age-related changes in drug metabolism and increased interaction risks. This population may benefit from structured discussions about symptom management goals and evidence-based alternatives. Documentation of use patterns becomes essential for medication reconciliation and adverse event monitoring. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Amrit%20Baral%3A%20Estimates%20of%20Cannabis%20and%20Classic%20Psychedelic%20Use%20Among%20Older%20U.S.%20Cancer%20Survivors%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Famrit-baral-estimates-of-cannabis-and-classic-psychedelic-use-among-older-u-s-ca%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Famrit-baral-estimates-of-cannabis-and-classic-psychedelic-use-among-older-u-s-ca%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Amrit%20Baral%3A%20Estimates%20of%20Cannabis%20and%20Classic%20Psychedelic%20Use%20Among%20Older%20U.S.%20Cancer%20Survivors%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Famrit-baral-estimates-of-cannabis-and-classic-psychedelic-use-among-older-u-s-ca%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://oncodaily.com/voices/amrit-baral-490918](https://oncodaily.com/voices/amrit-baral-490918) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating for this article?](#What_is_the_CED_Clinical_Relevance_rating_for_this_article) - [What medical specialties does this cannabis news relate to?](#What_medical_specialties_does_this_cannabis_news_relate_to) - [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221) - [What does “Notable Clinical Interest” mean for practitioners?](#What_does_8220Notable_Clinical_Interest8221_mean_for_practitioners) - [How does this cannabis news impact patient care?](#How_does_this_cannabis_news_impact_patient_care) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating for this article? This article has been assigned CED Clinical Relevance #70, which indicates “Notable Clinical Interest.” This rating is given to emerging findings or policy developments that are worth monitoring closely by [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### What medical specialties does this cannabis news relate to? The article covers multiple medical specialties including cancer care, geriatrics, and psychedelics. This suggests the cannabis-related findings have broad clinical applications across different patient populations and treatment areas. #### Why is this article marked as “New”? The “New” designation indicates this is recently published or updated content from CED Clinic. This helps [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) stay current with the latest developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and related therapeutic areas. #### What does “Notable Clinical Interest” mean for practitioners? Notable Clinical Interest suggests these are emerging findings or policy developments that clinicians should monitor closely. While not necessarily practice-changing immediately, these developments may influence future treatment decisions or clinical guidelines. #### How does this cannabis news impact patient care? Given its relevance to cancer care and geriatrics, this news likely provides important insights for treating patients in these vulnerable populations. Healthcare providers should stay informed about these developments to make evidence-based treatment decisions. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Society – Cannabis use among older adults is rising rapidly—especially for chronic pain …](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/) Explore the rising trend of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) among older adults, focusing on [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) and implications for healthcare providers. [Read More](https://cedclinic.com/cannabis-use-drug-interactions-older-adults/) [Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) Review findings from a large study linking [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use to significant pain relief, relevant to older cancer survivors. [Learn More](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) [Cannabis Warning Label Regulations and Characteristics in US States with Medical and …](https://cedclinic.com/cannabis-warning-label-regulations-and-characteristics-in-us-states-with-medical-and/) Understand cannabis warning label regulations across US states, important for patient safety and clinical guidance. [Explore Details](https://cedclinic.com/cannabis-warning-label-regulations-and-characteristics-in-us-states-with-medical-and/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).